![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | G01N 33/569 | |
G01N 33/577 | |||
C12N 15/03 |
(11) | Number of the document | 2823312 |
(13) | Kind of document | T |
(96) | European patent application number | 13710328.9 |
Date of filing the European patent application | 2013-03-08 | |
(97) | Date of publication of the European application | 2015-01-14 |
(45) | Date of publication and mention of the grant of the patent | 2019-08-07 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/EP2013/054670 |
Date | 2013-03-08 |
(87) | Number | WO 2013/132040 |
Date | 2013-09-12 |
(30) | Number | Date | Country code |
201261608293 P | 2012-03-08 | US |
(72) |
GIULIANI, Marzia, IT
MORI, Elena, IT
|
(73) |
GlaxoSmithKline Biologicals SA,
Rue de l`Institut 89, 1330 Rixensart,
BE
|
(54) | IN VITRO POTENCY ASSAY FOR PROTEIN-BASED MENINGOCOCCAL VACCINES |
IN VITRO POTENCY ASSAY FOR PROTEIN-BASED MENINGOCOCCAL VACCINES |